Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Caseys CASY stock a viable buying opportunity 083 20260420 TELO Telomir Pharmaceuticals gains slightly even as Q4 2025 EPS lands far below analyst consensus estimates elf Beauty ELF EPS surges 70 above estimates but stock drops 8 signaling investor concerns beyond the beat Dyne DYN Stock Next Week Technical Weakness 20260420 ACN Accenture delivers Q1 2026 EPS beat and 74 percent year over year revenue growth but shares drop 131 percent FCC Unprecedented Broadcast License Renewal Mandate for US Major Media Assets SPDR Gold Trust GLD Reassessing Allocations Inflation Hedge Narrative vs LowCorrelation Portfolio Utility The credit profile of Zurn Elkay ZWS revealed Q1 2026 Better Than Expected How Mexico MXF is solving the problems its peers cannot Steady 20260508 Oramed Pharmaceuticals ORMP Stock Slides 074 Support at 446 20260515 Should You Sell Malibu Boats MBUU After 365 Drop 20260515 Why Iron Horse IRHOR Just Surged 485 Key Levels Ahead 20260517 Luxury Industry Grapples with Inherent Contradictions as Exclusivity Evolves Spyre Therapeutics SYRE Stock Analysis Climbs 796 Eyes on 7552 20260520 BrownBrown BRO Q1 2026 Earnings Surprise EPS 139 Up Significant Citigroup Upgrades Arthur J Gallagher to Buy Citing Valuation and Cyclical Recovery Vermilion Energy Inc VET Declines 238 as Price Approaches Key Support Level Irans Potential Tariffs on Hormuz Internet Cables Could Raise Europes Connectivity Costs and Risks Frankfurt Airports New Sky Line Shuttle Faces Early Disruption Passengers Rerouted to Buses Microsoft and Anthropic in Talks for Custom AI Chip Deal After 5 Billion Investment Novartis Upgrades FullYear Outlook on Strong Portfolio Momentum SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Lags Vickers Insider Trading Report Highlights Buyers and Sellers for May 27 2026 ZURA Q1 2026 Earnings PreRevenue Biotech Reports WiderThanExpected Loss TUSK Q1 2026 Earnings EPS of 010 Amid Mixed Results Stock Declines 469 PHAR Q1 2026 Earnings EPS Misses Estimates by Wide Margin TVGN Q4 2025 Earnings NarrowerThanExpected Loss but No Revenue Growth Keeps Stock Under Pressure ELTX Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline Macerich MAC Nears Resistance After Modest Gains Supported by Real Estate Sector Momentum Empire Petroleum EP Edges Lower While Holding Key Support Zone Millennium Group International MGIH Edges Lower Amidst Consolidation Near Key Support LivePerson Inc LPSN Edges Higher as Stock Holds Above Key Support